A new tool provided a validated tumor recurrence and survival risk score for patients with lymph node-negative PanNETs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback